CAWACHI LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,848 JPY | +9.33% |
|
+7.43% | +7.31% |
| 01-30 | Cawachi’s Attributable Profit Up 4.8% in Fiscal Nine Months on Marginal Growth in Sales | MT |
| 01-25 | Cawachi Limited Provides Dividend Guidance for the Year Ending March 2024 | CI |
ETFs positioned on Cawachi Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.13% | 10 M€ | +9.06% | ||
| 0.01% | 18 M€ | +16.15% | - | |
| 0.01% | 20,721 M€ | +15.97% | - | |
| 0.01% | 66,066 M€ | +17.14% | - | |
| 0.01% | 144,586 M€ | +16.91% | ||
| 0.00% | 10 M€ | -3.35% | - |
CAWACHI LIMITED is a Japan-based company engaged in the operation of drugstores. The Company sells pharmaceutical products, including cold medicines, digestive medicines, various vitamin tablets, eye drops and nursing care items; cosmetics, including basic skin care products, makeup products and cosmetics for men; miscellaneous goods, including detergents, toilet papers, pet items and milk powders, as well as food products, including processed food products, dairy products, confectioneries, beverages and alcohol through its drugstores.
Sector
Drug Retailers
Calendar
23/07/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +7.31% | 371M | |
| -10.65% | 3.64B | |
| +1.28% | 3.38B | |
| -22.89% | 3.07B | |
| +7.42% | 2.68B | |
| +11.98% | 2.65B | |
| -7.95% | 1.76B | |
| +11.42% | 1.35B | |
| -19.60% | 984M | |
| -37.98% | 707M |
- Stock Market
- Equities
- 2664 Stock
- Funds and ETFs Cawachi Limited
